EGR1 and hepatocellular carcinoma: The aforementioned findings provide compelling evidence that the downregulation of EGR1 expression could potentially play a role in the emergence of sorafenib resistance in HCC. Subsequently, we proceeded to assess the IC50 values in HCC cells after alteration of EGR1 expression.